Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Music Therapy in Obsessive Compulsive Disorder [NA]
This completed clinical trial from Islamic Azad University investigated music therapy as a treatment for Obsessive-Compulsive Disorder, with…
-
FDA approval · 2014-12-01FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC, adding or updating labeling under the existing NDA.
-
FDA approval · 2014-11-26FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for PAROXETINE (paroxetine hydrochloride) from Zydus Lifesciences Limited, enabling the marketing of…
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Internet-delivered Attention Training for Obsessive-Compulsive Disorder [NA]
The clinical trial evaluating internet-delivered attention training for obsessive-compulsive disorder has completed. No results are provided…
-
FDA approval · 2014-11-07FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s generic sertraline hydrochloride under an Original Application (ANDA 202825).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-31FDA Approved: PAROXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for paroxetine hydrochloride hemihydrate (paroxetine), making a generic version of the…
-
FDA approval · 2014-10-27FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic version of sertraline. This action …
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder [Phase 2]
A Phase 2 trial evaluating add-on N-acetylcysteine for treatment-resistant obsessive-compulsive disorder has completed, with the update summ…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder. [NA]
This entry documents the completion of a pediatric obsessive-compulsive disorder trial focused on developing adaptive treatment strategies f…
-
FDA approval · 2014-10-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for fluoxetine.
-
FDA approval · 2014-10-10FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors [Phase 1]
A completed Phase 1 study evaluating how dopamine D2/D3 receptor agonist and antagonist drugs influence compulsive behaviors in obsessive-co…
-
FDA approval · 2014-09-12FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig.
-
FDA approval · 2014-09-11FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approves a supplemental application for Fluoxetine hydrochloride (fluoxetine) from PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2014-08-11FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for a fluoxetine hydrochloride generic product submitted by PAI Holdings (PAI Pharma).
-
FDA approval · 2014-07-18FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2014-07-18FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride generic from Lannett Company, Inc.
-
FDA approval · 2014-07-17FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for Fluoxetine from Aurobindo Pharma Limited, indicating continued approval of this generic produc…
-
FDA approval · 2014-07-16FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. The approval authorize…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders [Phase 2]
A Phase 2 trial evaluating riluzole for obsessive-compulsive disorder in children and adolescents, with or without autism spectrum disorders…
-
FDA approval · 2014-07-11FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, authorizing a new generic fluoxetine product under…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Internet-delivered CBT for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study [NA]
A pilot study evaluating internet-delivered cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Ketamine Infusion for Obsessive-Compulsive Disorder [Phase 2]
A Phase 2 clinical trial evaluating ketamine infusion for obsessive-compulsive disorder has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Family Based Treatment of Early Childhood Obsessive Compulsive Disorder [Phase 3]
This entry notes the completion of a Phase 3 trial evaluating Family Based Treatment for early childhood obsessive-compulsive disorder. The …
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder [NA]
This clinical trial update reports the completion and results posting of a study comparing risperidone versus cognitive-behavioral therapy t…